Payment overview · 2025
General Payments
$208.26
8 reported records · 5 companies
Healthcare provider profile · identity verified
John Edward Smith, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · ONEONTA, AL · NPI 1760553978
Verified facts
What the public records show
CMS Open Payments records show John Edward Smith, M.D. received $208.26 in general payments during 2025 across 8 reported records.
Boston Scientific Corporation accounted for 42.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 373 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 97 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 65 claims for Trulicity by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $87.57 | 42.0% | 3 | 2025 |
| Mannkind Corporation | Unresolved — no canonical attribution shown | $42.50 | 20.4% | 1 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $40.42 | 19.4% | 2 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $19.67 | 9.4% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $18.10 | 8.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $165.76 | 7 |
| Education | $42.50 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AFREZZA Normalized: afrezza |
Drug | Mannkind Corporation | $42.50 | 1 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $40.42 | 2 | 2025 |
Source payment records
|
|||||
| SpaceOAR System Normalized: spaceoar system |
Device | Boston Scientific Corporation | $34.01 | 1 | 2025 |
Source payment records
|
|||||
| CDS - Other Normalized: cds other |
Device | Boston Scientific Corporation | $30.53 | 1 | 2025 |
Source payment records
|
|||||
| LithoVue Elite Normalized: lithovue elite |
Device | Boston Scientific Corporation | $23.03 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $19.67 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $18.10 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 97 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
373 | 79 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
97 | 18 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
65 | 16 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2654 | 381 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1634 | 219 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1583 | 216 |
| Famotidine | Famotidine | 1489 | 176 |
| Amlodipine Besylate | Amlodipine Besylate | 1465 | 231 |
| Furosemide | Furosemide | 1389 | 153 |
| Potassium Chloride | Potassium Chloride | 1277 | 128 |
| Eliquis | Apixaban | 1143 | 84 |
| Lisinopril | Lisinopril | 1086 | 190 |
| Trazodone Hcl | Trazodone Hcl | 987 | 112 |
| Tamsulosin Hcl | Tamsulosin Hcl | 959 | 92 |
| Metformin Hcl | Metformin Hcl | 898 | 171 |
| Sertraline Hcl | Sertraline Hcl | 882 | 123 |
| Carvedilol | Carvedilol | 826 | 110 |
| Losartan Potassium | Losartan Potassium | 789 | 148 |
| Omeprazole | Omeprazole | 711 | 103 |
| Donepezil Hcl | Donepezil Hcl | 649 | 92 |
| Metoprolol Succinate | Metoprolol Succinate | 643 | 123 |
| Metoprolol Tartrate | Metoprolol Tartrate | 603 | 69 |
| Duloxetine Hcl | Duloxetine Hcl | 589 | 56 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 584 | 158 |
| Gabapentin | Gabapentin | 579 | 133 |
| Montelukast Sodium | Montelukast Sodium | 512 | 92 |
| Hydrochlorothiazide | Hydrochlorothiazide | 503 | 91 |
| Divalproex Sodium | Divalproex Sodium | 433 | 16 |
| Dicyclomine Hcl | Dicyclomine Hcl | 399 | 32 |
| Alendronate Sodium | Alendronate Sodium | 387 | 80 |
| Pravastatin Sodium | Pravastatin Sodium | 375 | 77 |
| Escitalopram Oxalate | Escitalopram Oxalate | 373 | 51 |
| Jardiance | Empagliflozin | 373 | 79 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 363 | 102 |
| Buspirone Hcl | Buspirone Hcl | 362 | 39 |
| Mirtazapine | Mirtazapine | 356 | 47 |
| Allopurinol | Allopurinol | 352 | 44 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 339 | 79 |
| Myrbetriq | Mirabegron | 336 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 331 | 28 |
| Quetiapine Fumarate | Quetiapine Fumarate | 319 | 36 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 308 | 16 |
| Clopidogrel | Clopidogrel Bisulfate | 308 | 71 |
| Tizanidine Hcl | Tizanidine Hcl | 303 | 36 |
| Sucralfate | Sucralfate | 283 | 49 |
| Azithromycin | Azithromycin | 273 | 213 |
| Primidone | Primidone | 259 | 15 |
| Glipizide Er | Glipizide | 255 | 65 |
| Methocarbamol | Methocarbamol | 247 | 40 |
| Simvastatin | Simvastatin | 247 | 38 |
| Baclofen | Baclofen | 244 | 16 |
| Meloxicam | Meloxicam | 244 | 55 |
| Memantine Hcl | Memantine Hcl | 244 | 14 |
| Divalproex Sodium Er | Divalproex Sodium | 236 | 14 |
| Farxiga | Dapagliflozin Propanediol | 233 | 37 |
| Hydralazine Hcl | Hydralazine Hcl | 233 | 18 |
| Meclizine Hcl | Meclizine Hcl | 233 | 38 |
| Alprazolam | Alprazolam | 221 | 37 |
| Ezetimibe | Ezetimibe | 221 | 54 |
| Lorazepam | Lorazepam | 220 | 40 |
| Valsartan | Valsartan | 220 | 24 |
| Spironolactone | Spironolactone | 218 | 29 |
| Ropinirole Hcl | Ropinirole Hcl | 210 | 26 |
| Atenolol | Atenolol | 209 | 28 |
| Ondansetron Hcl | Ondansetron Hcl | 202 | 53 |
| Pregabalin | Pregabalin | 199 | 51 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 180 | 71 |
| Citalopram Hbr | Citalopram Hydrobromide | 179 | 27 |
| Xarelto | Rivaroxaban | 178 | 19 |
| Cefdinir | Cefdinir | 177 | 141 |
| Tramadol Hcl | Tramadol Hcl | 168 | 42 |
| Methylprednisolone | Methylprednisolone | 167 | 133 |
| Clonazepam | Clonazepam | 159 | 32 |
| Bupropion Xl | Bupropion Hcl | 158 | 21 |
| Aripiprazole | Aripiprazole | 155 | 16 |
| Levetiracetam | Levetiracetam | 150 | 21 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 145 | 37 |
| Prazosin Hcl | Prazosin Hcl | 143 | suppressed |
| Linzess | Linaclotide | 136 | 31 |
| Fluconazole | Fluconazole | 135 | 93 |
| Fluticasone Propionate | Fluticasone Propionate | 133 | 39 |
| Topiramate | Topiramate | 132 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 131 | 16 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 130 | 70 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 127 | 32 |
| Clonidine Hcl | Clonidine Hcl | 126 | 27 |
| Doxycycline Hyclate | Doxycycline Hyclate | 120 | 82 |
| Fenofibrate | Fenofibrate | 120 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 120 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 118 | 19 |
| Pioglitazone Hcl | Pioglitazone Hcl | 117 | 36 |
| Amiodarone Hcl | Amiodarone Hcl | 115 | 19 |
| Benazepril Hcl | Benazepril Hcl | 115 | 18 |
| Ondansetron Odt | Ondansetron | 112 | 31 |
| Celecoxib | Celecoxib | 107 | 41 |
| Oxybutynin Chloride | Oxybutynin Chloride | 106 | 26 |
| Diclofenac Sodium | Diclofenac Sodium | 105 | 35 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 100 | suppressed |
| Risperidone | Risperidone | 100 | suppressed |
| Bumetanide | Bumetanide | 99 | 13 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 97 | 43 |
| Mounjaro | Tirzepatide | 97 | 18 |
| Amoxicillin | Amoxicillin | 96 | 70 |
| Calcitriol | Calcitriol | 95 | suppressed |
| Cephalexin | Cephalexin | 95 | 27 |
| Warfarin Sodium | Warfarin Sodium | 93 | 20 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 91 | 26 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 90 | 24 |
| Finasteride | Finasteride | 89 | 18 |
| Ozempic | Semaglutide | 89 | 23 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 87 | 12 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 86 | 17 |
| Januvia | Sitagliptin Phosphate | 85 | 20 |
| Paroxetine Hcl | Paroxetine Hcl | 85 | 15 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 84 | 21 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 84 | 48 |
| Lamotrigine | Lamotrigine | 84 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 84 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 82 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 82 | 29 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 81 | 11 |
| Olanzapine | Olanzapine | 81 | suppressed |
| Prednisone | Prednisone | 81 | 29 |
| Glimepiride | Glimepiride | 79 | 24 |
| Bupropion Hcl | Bupropion Hcl | 75 | suppressed |
| Glipizide | Glipizide | 75 | 15 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 75 | 17 |
| Nortriptyline Hcl | Nortriptyline Hcl | 74 | 26 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 72 | 21 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 72 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 69 | 15 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 69 | 23 |
| Roflumilast | Roflumilast | 69 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 67 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 67 | 16 |
| Estradiol | Estradiol | 66 | 24 |
| Metoclopramide Hcl | Metoclopramide Hcl | 65 | 15 |
| Trulicity | Dulaglutide | 65 | 16 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 62 | 23 |
| Chlorthalidone | Chlorthalidone | 60 | 21 |
| Lubiprostone | Lubiprostone | 60 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 60 | 16 |
| Mupirocin | Mupirocin | 60 | 37 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 60 | 14 |
| Nuplazid | Pimavanserin Tartrate | 59 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 59 | 55 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 58 | 14 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 58 | 45 |
| Synthroid | Levothyroxine Sodium | 57 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 57 | 22 |
| Benztropine Mesylate | Benztropine Mesylate | 54 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 54 | suppressed |
| Latanoprost | Latanoprost | 54 | 13 |
| Ursodiol | Ursodiol | 53 | suppressed |
| Verapamil Er | Verapamil Hcl | 52 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 51 | 13 |
| Levofloxacin | Levofloxacin | 51 | 35 |
| Breo Ellipta | Fluticasone/Vilanterol | 50 | 15 |
| Dapsone | Dapsone | 50 | suppressed |
| Lactulose | Lactulose | 50 | suppressed |
| Nystatin | Nystatin | 50 | 26 |
| Trospium Chloride | Trospium Chloride | 50 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 48 | suppressed |
| Digoxin | Digoxin | 47 | 13 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 46 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 46 | suppressed |
| Diazepam | Diazepam | 45 | 15 |
| Testosterone Cypionate | Testosterone Cypionate | 45 | 11 |
| Gemfibrozil | Gemfibrozil | 44 | suppressed |
| Torsemide | Torsemide | 44 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 44 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 43 | 11 |
| Mirabegron Er | Mirabegron | 42 | suppressed |
| Nystop | Nystatin | 42 | 13 |
| Naproxen | Naproxen | 41 | 13 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 41 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 40 | 25 |
| Symbicort | Budesonide/Formoterol Fumarate | 40 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 39 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 39 | suppressed |
| Ramipril | Ramipril | 39 | 11 |
| Terbinafine Hcl | Terbinafine Hcl | 39 | 16 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 38 | 38 |
| Ranolazine Er | Ranolazine | 38 | suppressed |
| Sotalol | Sotalol Hcl | 38 | suppressed |
| Vraylar | Cariprazine Hcl | 38 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 37 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 37 | 16 |
| Rizatriptan | Rizatriptan Benzoate | 36 | suppressed |
| Amantadine | Amantadine Hcl | 35 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 35 | 28 |
| Nitroglycerin | Nitroglycerin | 34 | 20 |
| Ibuprofen | Ibuprofen | 33 | 17 |
| Ziprasidone Hcl | Ziprasidone Hcl | 33 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 32 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 32 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 32 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 32 | suppressed |
| Lovastatin | Lovastatin | 31 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 31 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 29 | 13 |
| Valacyclovir | Valacyclovir Hcl | 29 | 22 |
| Azelastine Hcl | Azelastine Hcl | 28 | 11 |
| Clindamycin Hcl | Clindamycin Hcl | 28 | 18 |
| Hydrocortisone | Hydrocortisone | 28 | 11 |
| Lidocaine Hcl | Lidocaine Hcl | 28 | 19 |
| Gemtesa | Vibegron | 27 | suppressed |
| Rivastigmine | Rivastigmine | 27 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 27 | suppressed |
| Vascepa | Icosapent Ethyl | 27 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 26 | suppressed |
| Lacosamide | Lacosamide | 26 | suppressed |
| Metolazone | Metolazone | 26 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 25 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 24 | suppressed |
| Ketoconazole | Ketoconazole | 24 | 11 |
| Lidocaine | Lidocaine | 24 | suppressed |
| Neupro | Rotigotine | 24 | suppressed |
| Levemir | Insulin Detemir | 23 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 23 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 20 |
| Enalapril Maleate | Enalapril Maleate | 22 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 22 | 17 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Colchicine | Colchicine | 21 | 11 |
| Lansoprazole | Lansoprazole | 21 | suppressed |
| Mesalamine Er | Mesalamine | 21 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 21 | 20 |
| Pentoxifylline | Pentoxifylline | 21 | suppressed |
| Prolia | Denosumab | 21 | 12 |
| Sevelamer Hcl | Sevelamer Hcl | 21 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 20 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 20 | suppressed |
| Budesonide | Budesonide | 19 | suppressed |
| Repaglinide | Repaglinide | 19 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 18 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 18 | suppressed |
| Irbesartan | Irbesartan | 18 | suppressed |
| Metronidazole | Metronidazole | 18 | 15 |
| Sevelamer Carbonate | Sevelamer Carbonate | 18 | suppressed |
| Cholestyramine Light | Cholestyramine | 17 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 17 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 17 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 17 | suppressed |
| Trulance | Plecanatide | 17 | suppressed |
| Almotriptan Malate | Almotriptan Malate | 16 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 16 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 16 | suppressed |
| Humalog | Insulin Lispro | 16 | suppressed |
| Indapamide | Indapamide | 16 | suppressed |
| Klor-Con M20 | Potassium Chloride | 16 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 16 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 15 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 15 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 15 | suppressed |
| Dulera | Mometasone/Formoterol | 15 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 14 | suppressed |
| Austedo | Deutetrabenazine | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | 12 |
| Cholestyramine | Cholestyramine (With Sugar) | 14 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 14 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Tacrolimus | Tacrolimus | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 13 | suppressed |
| Budesonide Dr | Budesonide | 13 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 13 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 13 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 13 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 13 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 13 | suppressed |
| Oxtellar Xr | Oxcarbazepine | 13 | suppressed |
| Ruconest | C1 Esterase Inhibitor, Recomb | 13 | suppressed |
| Rybelsus | Semaglutide | 13 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 13 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Cyclosporine | Cyclosporine | 12 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 12 | 12 |
| Pilocarpine Hcl | Pilocarpine Hcl | 12 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Cilostazol | Cilostazol | 11 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 11 | suppressed |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | 11 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 11 | suppressed |
| Nifedipine Er | Nifedipine | 11 | suppressed |
| Paxlovid (Eua) | Nirmatrelvir/Ritonavir | 11 | suppressed |
| Probenecid | Probenecid | 11 | suppressed |
| Repatha Sureclick | Evolocumab | 11 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 11 | suppressed |
| Xtampza Er | Oxycodone Myristate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $208.26 · 8 records | Boston Scientific Corporation | AFREZZA, CDS - Other, Kerendia, LithoVue Elite, MOUNJARO, SpaceOAR System, The Cologuard Plus Collection Kit | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Mounjaro play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error